RxDoctor Payments Data

Jack Vu

Family Medicine · Long Beach, CANPI 1083885826

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,859 of the $2,105 with a category attached, or 88.3%. Eli Lilly accounts for 98.3% of it on its own, with 1 other manufacturer making up the rest.

$2,105in general payments, 2019–2025

Across 13 payments — averaging $161.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • Aimmune Therapeutics, Inc.$36
$10,400,197in research payments, 2019–2025

Across 2,754 payments — averaging $3776.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$5.1M
  • Eli Lilly$1.4M
  • Janssen Research & Development, LLC$1.3M
  • Pfizer$803K
  • Amgen$455K
  • Roche Diagnostics Operations, Inc.$393K
  • plus $888K from 13 others

What the payments were for

  • Travel & lodging$1,85988%
  • Food & beverage$24612%

General payments by program year

22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly11$2,069
Aimmune Therapeutics, Inc.2$36

How this compares

$2,105 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California →

Other family medicine in Long Beach

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →